Resveratrol inhibits oligomeric Aβ-induced microglial activation via NADPH oxidase

Molecular Medicine Reports

Volumn 12, Issue 4, 2015, Pages 6133-6139

  Yao, Yao ^a,b   Li, Juan ^c,d   Niu, Yang ^c,e   Yu, Jian Qiang ^c,f   Yan, Ling ^a   Miao, Zhen Hua ^a   Zhao, Xun Xia ^a   Li, Yuan Jie ^a   Yao, Wan Xia ^c   Zheng, Ping ^c   Li, Wei Qi ^g,h  

^a School of Basic Medical Science   (China)

^b Research Center of Medical Science and Technology   (China)

^c NINGXIA MEDICAL UNIVERSITY   (China)

^d Ningxia Engineering and Technology Research Center for Modernization of Hui Medicine   (China)

^e BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^f Ningxia Hui Medicine Modern Engineering Research Center   (China)

^g INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^h China National Center for Biotechnology Development   (China)

Author keywords

Alzheimer's disease; BV 2 microglia; NADPH oxidase; Oligomeric amyloid ; Resveratrol

Indexed keywords

AMYLOID BETA PROTEIN; GLYCOPROTEIN GP47 PHOX; INTERLEUKIN 1BETA; MESSENGER RNA; NATURAL PRODUCT; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; RESVERATROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; CYBB PROTEIN, MOUSE; IL1B PROTEIN, MOUSE; MEMBRANE PROTEIN; NEUROPROTECTIVE AGENT; NEUTROPHIL CYTOSOLIC FACTOR 1; STILBENE DERIVATIVE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; ASSAY; BROMODEOXYURIDINE INCORPORATION ASSAY; CELL ACTIVATION; CELL COUNTING; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; MICROGLIA; MOUSE; NONHUMAN; PROTEIN EXPRESSION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; METABOLISM;

AMYLOID BETA-PEPTIDES; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL PROLIFERATION; CELLS, CULTURED; INTERLEUKIN-1BETA; MEMBRANE GLYCOPROTEINS; MICE; MICROGLIA; NADPH OXIDASE; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; REACTIVE OXYGEN SPECIES; STILBENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84940471066     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.4199     Document Type: Article

References (31)

1. Glass CK, Saijo K, Winner B, Marchetto MC and Gage FH: Mechanisms underlying infammation in neurodegeneration. Cell 140: 918-934, 2010.
2. Kawabori M and Yenari MA: The role of the microglia in acute CNS injury. Metab Brain Dis 30: 381-392, 2014.
3. Block ML, Zecca L and Hong JS: Microglia-mediated neuro-toxicity: Uncovering the molecular mechanisms. Nat Rev Neurosci 8: 57-69, 2007.
4. Markus MA and Morris BJ: Resveratrol in prevention and treatment of common clinical conditions of aging. Clin Interv Aging 3: 331-339, 2008.
5. Ponzo V, Soldati L and Bo S: Resveratrol: a supplementation for men or for mice? J Transl Med 12: 158, 2014.
6. de la Lastra CA and Villegas I: Resveratrol as an anti-inflammatory and anti-aging agent: Mechanisms and clinical implications. Mol Nutr Food Res 49: 405-430, 2005.
7. Lorenz P, Roychowdhurys, Engelmann M, Wolf G and Horn TF: Oxyresveratrol and resveratrol are potent antioxidants and free radical scavengers: Effect on nitrosative and oxidative stress derived from microglial cells. Nitric Oxide 9: 64-76, 2003.
8. Bi XL, Yang JY, Dong YX, Wang JM, Cui YH, Ikeshima T, Zhao YQ and Wu CF: Resveratrol inhibits nitric oxide and TNF-alpha production by lipopolysaccharide-activated microglia. Int Immunopharmacol 5: 185-193, 2005.
9. Candelario-Jalil E, de Oliveira AC, Gräfs, Bhatia HS, Hüll M, Muñoz E and Fiebich BL: Resveratrol potently reduces prostaglandin E2 production and free radical formation in lipopolysaccharide-activated primary rat microglia. J Neuroinfammation 4: 25, 2007.
10. Lu X, Ma L, Ruan L, Kong Y, Mou H, Zhang Z, Wang Z, Wang JM and Le Y: Resveratrol differentially modulates infammatory responses of microglia and astrocytes. J Neuroinfammation 7: 46, 2010.
11. Zekry D, Epperson TK and Krause KH: A role for NOX NADPH oxidases in Alzheimer's disease and other types of dementia? IUBMB Life 55: 307-313, 2003.
12. Capiralla H, Vingtdeux V, Zhao H, Sankowski R, Al-Abed Y, Davies P and Marambaud P: Resveratrol mitigates lipopolysac-charide-and Aβ-mediated microglial infammation by inhibiting the TLR4/NF-κB/STAT signaling cascade. J Neurochem 120: 461-472, 2012.
13. Choi SH, Aid S, Kim HW, Jackson SH and Bosetti F: Inhibition of NADPH oxidase promotes alternative and anti-inflammatory microglial activation during neuroinflam-mation. J Neurochem 120: 292-301, 2012.
14. McLean CA, Cherny RA, Fraser FW, FullersJ, Smith MJ, Beyreuther K, Bush AI and Masters CL: Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol 46: 860-866, 1999.
15. Mc Donald JM, Savva GM, Brayne C, Welzel AT, Forster G, Shankar GM, Selkoe DJ, Ince PG and Walsh DM; Medical Research Council Cognitive Function and Ageing Study: The presence of sodium dodecyl sulphate-stable Abeta dimers is strongly associated with Alzheimer-type dementia. Brain 133: 1328-1341, 2010.
16. Li J, Yang JY, Yao XC, Xue X, Zhang QC, Wang XX, Ding LL and Wu CF: Oligomeric Aβ-induced microglial activation is possibly mediated by NADPH oxidase. Neurochem Res 38: 443-452, 2013.
17. Bargers W and Harmon AD: Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 388: 878-881, 1997.
18. Groemping Y and Rittinger K: Activation and assembly of the NADPH oxidase: A structural perspective. Biochem J 386: 401-416, 2005.
19. Giuliani F, Hader W and Yong VW: Minocycline attenuates T cell and microglia activity to impair cytokine production in T cell-microglia interaction. J Leukoc Biol 78: 135-143, 2005.
20. Maezawa I, Zimin PI, Wulff H and Jin LW: Amyloid-beta protein oligomer at low nanomolar concentrations activates microglia and induces microglial neurotoxicity. J Biol Chem 286: 3693-3706, 2011.
21. 2 derived from NADPH oxidase: A cell culture study. J Neuroinfamm 3: 24, 2006.
22. Green S P, Cairns B, Rae J, Errett-Baroncini C, Hongo JA, Erickson RW and Curnutte JT: Induction of gp91-phox, a component of the phagocyte NADPH oxidase, in microglial cells during central nervous system infammation. J Cereb Blood Flow Metab 21: 374-384, 2001.
23. Klegeris A and McGeer PL: Rat brain microglia and peritoneal macrophages show similar responses to respiratory burst stimulants. J Neuroimmunol 53: 83-90, 1994.
24. Babior BM: Oxidants from phagocytes: Agents of defense and destruction. Blood 64: 959-966, 1984.
25. Qin L, Liu Y, Wang T, Wei SJ, Block ML, Wilson B, Liu B and Hong JS: NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinfammatory gene expression in activated microglia. J Biol Chem 279: 1415-1421, 2004.
26. Leonard SS, Xia C, Jiang BH, Stinefelt B, Klandorf H, Harris GK and Shi X: Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem Biophys Res Commun 309: 1017-1026, 2003.
27. Spanier G, Xu H, Xia N, Tobias S, Deng S, Wojnowski L, Forstermann U and Li H: Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4). J Physiol Pharmacol 60 (Suppl 4): 111-116, 2009.
28. Banati RB, Gehrmann J, Schubert P and Kreutzberg GW: Cytotoxicity of microglia. Glia 7: 111-118, 1993.
29. Hur J, Lee P, Kim MJ, Kim Y and Cho YW: Ischemia-activated microglia induces neuronal injury via activation of gp91phox NADPH oxidase. Biochem Biophys Res Commun 391: 1526-1530, 2010.
30. Wilms H, Sievers J, Rickert U, Rostami-Yazdi M, Mrowietz U and Lucius R: Dimethylfumarate inhibits microglial and astrocytic infammation by suppressing the synthesis of nitric oxide, IL-1beta, TNF-alpha and IL-6 in an in-vitro model of brain infammation. J Neuroinfammation 7: 30, 2010.
31. Eikelenboom P, Veerhuis R, Scheper W, Rozemuller AJ, van Gool WA and Hoozemans JJ: The signifcance of neuroinfammation in understanding Alzheimer's disease. J Neural Transm 113: 1685-1695, 2006.